Publications by authors named "Rahaf Adnan Kh Al Zeer"
Int J Alzheimers Dis
July 2024
Article Synopsis
- Alzheimer's disease (AD) is characterized by the buildup of amyloid-beta proteins and tangles in the brain, and recent advancements in antiamyloid therapy aim to address this condition.
- Lecanemab, a newly approved monoclonal antibody, has shown promise in slowing cognitive decline for early AD and mild cognitive impairment, yet it presents challenges including side effects and the need for additional tests.
- Future research is needed to develop preventive strategies for AD and create more accessible and cost-effective treatments that target various aspects of the disease.
